Better data for over 20 years
Transoma Medical was founded in 1984 as Data Sciences International (DSI), a pioneer in the use of implantable wireless devices for monitoring and collecting physiological data in biomedical research.
Over the past twenty years, DSI has established itself as the leading provider of implantable, wireless, physiologic monitoring equipment for biomedical research applications, and a significant supplier of related data acquisition and analysis products.
In 2003 the Patient Management Division was formed, leveraging its core DSI technology, patent portfolio and biomedical research infrastructure to commercialize human clinical diagnostic systems and paving the way for the formation of Transoma Medical.
In October, 2007, Transoma Medical received FDA clearance for the Sleuth Implantable ECG Monitoring System — the first wireless and automated monitoring system available to capture long-term ECG data for diagnosing cardiac arrhythmias.
In February, 2009, Transoma Medical received FDA clearance for its second-generation product, the Sleuth AT Implantable Cardiac Monitoring System. With Sleuth AT, physicians can now program the capture of high-quality ECG samples at frequent intervals. This capability offers new and unique insight for physicians who manage patients with complex cardiac arrhythmias. For some patients, providing physicians the ability to monitor their arrhythmias over the long term is important because cardiac arrhythmias can be dangerous, often occur without symptoms and therapies prescribed to control them can become ineffective over time.
These devices are the first, in a series of future generation products from Transoma Medical, designed to provide timely, relevant information to help physicians optimize patient treatment.
